The term Teneurin-1 Activators would refer to a specialized category of chemical compounds that selectively increase the biological activity of Teneurin-1, a transmembrane protein that plays a significant role in cellular signaling and development. Teneurin-1 is part of the teneurin family, which is known to be involved in processes such as neuronal development and cellular communication. The teneurins are characterized by their large size and complex domain structure, which includes an intracellular domain with bioactive peptide sequences and a large extracellular domain that may be involved in intercellular interactions. Activators of Teneurin-1 would typically be molecules that enhance its signaling capacity or stabilize its active conformation. To successfully identify such activators, a comprehensive understanding of Teneurin-1's molecular architecture and interaction points is crucial. This would likely involve in-depth structural studies, employing advanced techniques like cryo-electron microscopy or X-ray crystallography, to ascertain the precise binding sites and conformational changes associated with its activation. Moreover, understanding the endogenous ligands or conditions that naturally modulate Teneurin-1 activity would provide valuable insights for the design of activator molecules.
In the process of identifying and developing Teneurin-1 activators, a multifaceted approach would be adopted, starting with the screening of extensive chemical libraries to find candidate molecules with the potential to interact with and activate Teneurin-1. High-throughput screening assays, tailored to detect upregulation of Teneurin-1 activity, would serve as a primary tool in this discovery phase. Following the identification of potential activator molecules through these screens, detailed biochemical and biophysical studies would be necessary to confirm the activation mechanism. This would involve a series of experiments designed to elucidate how these molecules influence Teneurin-1 function, such as by binding assays, mutagenesis studies to identify critical residues for activator interaction, and functional assays to monitor consequent changes in cellular signaling. The optimization phase for these activators would revolve around refining their specificity and enhancing their molecular interaction with Teneurin-1. Chemists and molecular modelers would iteratively modify the chemical structure of these compounds, guided by insights from structure-activity relationship (SAR) analysis. The goal would be to achieve high-affinity activators that are capable of modulating Teneurin-1 in a controlled manner. Through these rigorous processes, Teneurin-1 activators would be refined to the point where they could be used as precise molecular probes, contributing to a deeper understanding of Teneurin-1's role in cellular communication and its broader biological significance.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
May regulate gene expression during neural development and potentially increase Teneurin-1 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
As a steroid hormone, it could modulate gene expression in neural tissues, possibly affecting Teneurin-1 levels. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor that could lead to demethylation and activation of the Teneurin-1 gene. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Acts as a histone deacetylase inhibitor, potentially leading to upregulation of Teneurin-1 through chromatin remodeling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Like valproic acid, it inhibits histone deacetylase, possibly leading to increased expression of Teneurin-1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects glycogen synthase kinase-3 (GSK-3) signaling, which may impact Teneurin-1 expression in neural cells. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Increases intracellular cAMP levels, which could influence Teneurin-1 expression through cAMP response element-binding protein (CREB). | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Histone deacetylase inhibitor that may promote expression of genes involved in neural development including Teneurin-1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Might modulate gene expression related to neural development and synaptic plasticity, potentially affecting Teneurin-1. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
A cAMP analog that may mimic the activation of cAMP-dependent pathways, possibly leading to Teneurin-1 expression. | ||||||